ICU Medical, Inc. / Pfizer Inc. (Hospira Infusion Systems business)
2016 · Asset Purchase · $1.0B · Complete
Announcement Sentiment
86
Strongly positive
ICU Medical agreed to acquire Pfizer's Hospira Infusion Systems business (IV pumps, solutions, devices) for $1B in cash and stock: $600M cash plus $400M in newly issued ICU Medical shares (giving Pfizer a 16.4% stake). Combined company pro forma revenue ~$1.45B. Final consideration adjusted to ~$900M for performance changes. Closed February 6, 2017.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
AnnouncedOct 06, 2016
ClosedFeb 06, 2017
Deal value$1.0B
Deal typeAsset Purchase
Therapeutic areaN/A (infusion devices/solutions)
IndicationsN/A (infusion devices/solutions)
Key assetsHospira Infusion Systems (IV pumps, solutions, devices)